Kestra Medical Technologies, Ltd. Marketable Securities, Unrealized Gain (Loss)
Kestra Medical Technologies, Ltd. (KMTS) reported Marketable Securities, Unrealized Gain (Loss) of -$253.00 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2026-09-14
- Kestra Medical Technologies, Ltd. marketable securities, unrealized gain (loss) for the quarter ending 2026-07-31 was -$253.00K.
- Kestra Medical Technologies, Ltd. marketable securities, unrealized gain (loss) for fiscal 2026 was -$218.00K.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|
| 2026-07-31 | -$253.00K 10-Q · filed 2026-09-14 | |
| 2026-04-30 | -$218.00K 10-K · filed 2026-07-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |